Article
Insulin-like growth factor binding protein-2: contributions of the C-terminal domain to insulin-like growth factor-1 binding.
Molecular pharmacology - 1 Mar 2006
Kibbey Megan M, Jameson Mark J, Eaton Erin M, Rosenzweig Steven A
Abstract excerpt
Signaling by the insulin-like growth factor (IGF)-1 receptor (IGF-1R) has been implicated in the promotion and aggressiveness of breast, prostate, colorectal, and lung cancers. The IGF binding proteins (IGFBPs) represent a class of natural IGF antagonists that bind to and sequester IGF-1/2 from the IGF-1R, making them attractive candidates as therapeutics for cancer prevention and control. Recombinant human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
